Work

Patient Co-Morbidity Profile Should Drive PI3K Inhibitor Selection for Relapsed Follicular Lymphoma

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-110477

Authors: Farrukh T. Awan, Rebecca J Chan, Wei Ye, Guan Xing, Caroline Roudet, Bianca Ruzicka, Martin Dreyling, Pier Luigi Zinzani, Ajay K. Gopal

Institutions: The Ohio State University, Gilead Sciences (United States), Ludwig-Maximilians-Universität München, Istituto di Ematologia di Bologna, Seattle Cancer Care Alliance

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2966591163

Cites:

Cited by:

Related to: 10